Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Alt text (EN) This picture shows several doctors looking at a medical image within the program mint Lesion™

On-Site BZKF BORN Roll-Out Trainings Keep on Going

Our expert Steffen Rupp recently visited the Technical University of Munich to continue the on-site BZKF BORN Roll-Out Trainings.

As mentioned earlier this month in a press release by the Bayerisches Zentrum für Krebsforschung (BZKF), the second funding for the BORN project was launched and the project is in full swing: the templates that were previously developed at six university hospitals are now being used and tested in their clinical routine.

What does the BZKF BORN project do? The goal of the Bavaria-wide Oncological Radiology Network (BORN) is to help patients and healthcare professionals across the state. The project carries out cancer imaging examinations in a standardized manner, evaluates them systematically, and establishes the requisite framework for data collection and exchange. It thus creates a globally unique data base for diagnosing and treating cancer.

Mint Medical and Brainlab are working closely with the university hospitals and the Bayerisches Zentrum für Krebsforschung (BZKF) to establish uniform and structured reporting in oncological imaging, as well as to develop a secure IT infrastructure for the capture and exchange of data.

(Image shows anonymized demo case.)

Further information about the project is available here: www.bzkf.de/born/

Related Resources

Related Resources

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…

Image shows graphic related to study's research on iRECIST and RECIST

University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…

Doctors holding up puzzle pieces

Developing Standardized Reporting Templates for Sarcomas: Insights from Prof. Dr. Wolfgang Kunz

Sarcomas are a rare and heterogeneous group of malignant tumors that pose significant challenges in both diagnosis and treatment. Within the framework…